Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Behçet's Disease Presenting with Acute Transverse Myelitis: MRI Findings and Review of the Nosology. A Case Report.
Epidermal pigmentation in the human lineage is an adaptation to ultraviolet radiation.
Impact of Cigarette Smoking on Conversion from Clinically Isolated Syndrome to Clinically Definite Multiple Sclerosis.
Neuromyelitis optica with very late onset.
Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases.
Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS] (RECYCLINE)
Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis.
JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.
Emerging tumefactive MS after switching therapy from interferon-beta to fingolimod: A case report.
Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome.
Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening.
The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis-Report of Two Cases.
Immunohistochemical detection of sphingosine-1-phosphate and sphingosine kinase-1 in human tissue samples.
Interpretation and visualization of non-linear data fusion in kernel space: study on metabolomic characterization of progression of multiple sclerosis.
Effects of Dalfampridine Extended-Release Tablets on 6-Minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-Blind, Placebo-Controlled Trial.
Novartis updates US label on Gilenya® following discussions with the FDA
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
Partnering to increase access to community exercise programs for people with stroke, acquired brain injury, and multiple sclerosis.
[Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera®/Gilenya®) for the treatment of multiple sclerosis].
Functional role of TRP channels in modulating ER stress and Autophagy.
Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort.
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.
Autoinflammatory grey matter lesions in humans: cortical encephalitis, clinical disorders, experimental models.
Central nervous system lymphoma associated with natalizumab.

Pages